Picture of Urticaria
Title: Picture of UrticariaCategory: ImagesCreated: 1/5/2010 4:22:00 PMLast Editorial Review: 6/28/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 28, 2022 Category: Dermatology Source Type: news
Chilblains: An Old But Now More Common Problem
Discussion
Chilblains is also known as perniosis is an “…inflammatory dermatosis that generally affects the dorsal feet or hands during the periods of damp and cold, but not freezing, conditions…” It produces acryl lesions.
Chilblains may be derived from the Old English words “chill” and “blegen” (sore). Pernio is thought be derivative of pern(a) or haunch of the leg as the feet and legs are commonly affected. Chilblain is usually idiopathic but has been associated with Raynaud disease, blood problems including cryofibrinogenemia and rheumatologic conditions such as systemic ...
Source: PediatricEducation.org - May 30, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Teenager is so allergic to water she cannot cry due to painful hives when liquid touches her skin
Abigail Beck, 15, from Tucson, Arizona, was last month diagnosed with aquagenic urticaria - a condition that causes hives when skin comes into contact with water. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2022 Category: Consumer Health News Source Type: news
What is in the Differential Diagnosis for Black and White Skin Conditions?
Discussion
This is the third in a short case series of differential diagnoses of colored skin conditions.
An introduction to dermatological terminologies and information about colors can be can be found here.
A differential diagnosis by distribution and common pattern can be found here.
For red, orange and yellow conditions, a review can be found here.
For green, blue and purple conditions, a review can be found here.
For brown and grey conditions, a review can be found here.
Note that any color can be a normal variant for an individual or is physiologic for a given state. When lesions of the opposite color of the normal s...
Source: PediatricEducation.org - May 9, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Activity Score Helps Cold Urticaria Patients Monitor Illness Activity Score Helps Cold Urticaria Patients Monitor Illness
A 4-question rating scale enables people with cold urticaria monitor their illness, researchers report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 4, 2022 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Covid symptoms: Hives, prickly heat or chilblains are infection warnings found on skin
COVID symptoms, according to public health authorities, are a cough, fever and difficulty breathing. But other symptoms have since joined the list including those related to your skin. (Source: Daily Express - Health)
Source: Daily Express - Health - April 28, 2022 Category: Consumer Health News Source Type: news
Asthma drug can block crucial SARS-CoV-2 protein
A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science (IISc).
Approved by the US Food and Drug Administration (FDA), the drug, called montelukast, has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever and hives. (Source: World Pharma News)
Source: World Pharma News - April 25, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Basel, 25 April 2022Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early...
Source: Roche Media News - April 25, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early-stage non-small cel...
Source: Roche Investor Update - April 25, 2022 Category: Pharmaceuticals Source Type: news
IISc researchers find Asthma drug Montelukast can block crucial SARS-CoV-2 protein
Approved by the US Food and Drug Administration (FDA), the drug, called montelukast, has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever and hives. (Source: The Economic Times)
Source: The Economic Times - April 25, 2022 Category: Consumer Health News Source Type: news
Chronic Spontaneous Urticaria Responds Quickly to BTK Inhibitor
(MedPage Today) -- BOSTON -- A form of chronic hives improved quickly and significantly in response to treatment with a novel Bruton's tyrosine kinase (BTK) inhibitor, a multicohort dose-finding study showed.
As many as a fourth of patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 31, 2022 Category: Dermatology Source Type: news
U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
TITUSVILLE, N.J., March 29, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (cabotegravir and rilpivirine) for the treatment of HIV-1 in virologically suppressed adolescents (HIV-1 RNA less than 50 copies per milliliter [c/mL]) who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.1,2 Co-developed as part of a collaboration with ViiV Healthcare, CABENUVA is the first ...
Source: Johnson and Johnson - March 30, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
U.S. FDA Approves Streamlined Process for Initiating HIV Therapy with CABENUVA (cabotegravir and rilpivirine), the First and Only Complete Long-Acting Injectable HIV Treatment
TITUSVILLE, N.J., March 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a label update for CABENUVA (cabotegravir and rilpivirine), giving healthcare professionals and people living with human immunodeficiency virus (HIV-1) in the U.S. the option to start this once-monthly or every-two-month injectable treatment without the need for the oral lead-in phase (daily cabotegravir and rilpivirine tablets, taken for one month prior to initiation of cabotegravir and rilpivirine injections).1 Clinical data demonstrated the regimen di...
Source: Johnson and Johnson - March 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Childhood Cold Allergy Lingers and Raises Risk for Anaphylaxis Childhood Cold Allergy Lingers and Raises Risk for Anaphylaxis
Children with cold urticaria had an elevated risk for anaphylaxis, and resolution often took years, a study from Canada reports.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2022 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news
What Do Stress Hives Look Like?
Title: What Do Stress Hives Look Like?Category: Diseases and ConditionsCreated: 3/7/2022 12:00:00 AMLast Editorial Review: 3/7/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 7, 2022 Category: Dermatology Source Type: news
